APA (7th ed.) Citation

A, V., C, v. B., A, S., R, S., E, B., G, S., . . . L, O. (2025). Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment? Journal of cancer research and clinical oncology, 151(2), 44. https://doi.org/10.1007/s00432-025-06090-4

Chicago Style (17th ed.) Citation

A, Volk, von Bülow C, Stern A, Simon R, Burandt E, Sauter G, Schmalfeldt B, and Oliveira-Ferrer L. "Stromal PDGFR-beta Expression Is a Prognostic Factor in High-grade Serous Ovarian Cancer Patients but Is It Also Predictive for Response to Antiangiogenic Treatment?" Journal of Cancer Research and Clinical Oncology 151, no. 2 (2025): 44. https://doi.org/10.1007/s00432-025-06090-4.

MLA (9th ed.) Citation

A, Volk, et al. "Stromal PDGFR-beta Expression Is a Prognostic Factor in High-grade Serous Ovarian Cancer Patients but Is It Also Predictive for Response to Antiangiogenic Treatment?" Journal of Cancer Research and Clinical Oncology, vol. 151, no. 2, 2025, p. 44, https://doi.org/10.1007/s00432-025-06090-4.